Strategic Partners A/S (OZYMF)
Strategic Partners A/S operates in the Biotechnology industry of the Healthcare sector, headquartered in Copenhagen, CR, DK. The stock last traded at $90.00, up 0.00% on the session, giving a market capitalisation of $3.7M. On trailing twelve-month figures it carries a trailing P/E of 21.68, a net margin of 329.3%. Its beta of 0.27 implies it has historically moved less than the broad market.
Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.
Strategic Partners A/S is most often compared with the following Healthcare names: